To Whom It May Concern:
My wife and I own a lakefront property at 552 Saunders Avenue in Akron, Ohio, which we put on the market in mid-September 2024. On September 23, we accepted an offer of $540,000 from a prospective buyer. Initial inspections were completed on September 26, and the buyers approved the property pending radon test results.
On September 29, the buyers received a radon report showing an average radon level of 317.3 pCi/l, with fluctuations from 1,043 pCi/l down to 75 pCi/l over a 71-hour period. Given that one of the buyers is a cancer survivor, this high reading led them to withdraw their offer on October 1.
Our realtor immediately questioned the accuracy of this report, as a fluctuation of over 1,000 pCi/l within 71 hours is highly irregular. She contacted both radon testing and mitigation professionals, who agreed a retest was necessary. However, the buyer’s agent dismissed this recommendation, asserting that the buyers were no longer interested.
We then commissioned a second test, which, on October 4, returned a reading of only 1.8 pCi/l. Subsequently, Arrow Environmental’s retest on October 7 confirmed a low reading of 2.3 pCi/l. Upon investigation, Radalink, LLC, the company that processed the initial report, acknowledged a faulty charger caused the inaccurate reading. Although their process includes a review for extreme test results, our report was sent without this audit.
I believe Radalink LLC’s negligence in failing to review the test results cost us this sale. A cancer survivor, presented with such high radon levels, would understandably be deterred, especially with a five-day delay in receiving valid results.
This issue could have been entirely avoided had Radalink properly audited their findings. I have attempted to contact Radalink’s management without response. I request that Radalink provide a proposal to resolve this matter and address the loss incurred.
Thank you for your attention to this issue.
Sincerely,
Greg McNeil